| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shuba Kumar, Rani Mohanraj, Rajiv Raman, Geetha Kumar, Sanjay Luvies, Shivani Sunil Machhi, Subhratanu Chakrabarty, Janani Surya, Radha Ramakrishnan, Dolores Conroy, Sobha Sivaprasa. 'I don`t need an eye check-up'. A qualitative study using a behavioural model to understand treatment-seeking behaviour of patients with sight threatening diabetic retinopathy (STDR) in India. PloS one. vol 18. issue 6. 2023-06-15. PMID:37319187. |
according to the world health organization (who), dr is responsible for37 million cases of blindness worldwide. |
2023-06-15 |
2023-08-14 |
Not clear |
| Lei Zha. Frontiers in Understanding the Pathological Mechanism of Diabetic Retinopathy. Medical science monitor : international medical journal of experimental and clinical research. vol 29. 2023-06-13. PMID:37307243. |
epidemiological data show that dr is a leading cause of blindness in working-aged adults. |
2023-06-13 |
2023-08-14 |
Not clear |
| Wei Zhao, Yanli Liu, Cairui Li, Zhijian Yin, Yi Liu, Meixia A. Mechanisms of MALAT1 regulating proliferative diabetic retinopathy via targeting miR-126-5p. American journal of translational research. vol 15. issue 5. 2023-06-12. PMID:37303661. |
diabetic retinopathy (dr) is the primary reason for blindness among the middle-aged and elderly. |
2023-06-12 |
2023-08-14 |
Not clear |
| Xin Wen, Tsz Kin Ng, Qingping Liu, Zhenggen Wu, Guihua Zhang, Mingzhi Zhan. Azelaic acid and guanosine in tears improve discrimination of proliferative from non-proliferative diabetic retinopathy in type-2 diabetes patients: A tear metabolomics study. Heliyon. vol 9. issue 5. 2023-06-12. PMID:37305454. |
diabetic retinopathy (dr) is the microvascular ocular complication of diabetes mellitus (dm), which can lead to irreversible blindness and visual impairment if not properly treated. |
2023-06-12 |
2023-08-14 |
Not clear |
| Brijesh Kumar Chaurasia, Harsh Raj, Shreya Singh Rathour, Piyush Bhushan Sing. Transfer learning-driven ensemble model for detection of diabetic retinopathy disease. Medical & biological engineering & computing. 2023-06-09. PMID:37296285. |
if dr is not treated, it can become severe, damage vision, and eventually result in blindness. |
2023-06-09 |
2023-08-14 |
Not clear |
| Abere Woretaw Azagew, Yeneabat Birhanu Yohanes, Zerko Wako Beko, Yohannes Mulu Ferede, Chilot Kassa Mekonne. Determinants of diabetic retinopathy in Ethiopia: A systematic review and meta-analysis. PloS one. vol 18. issue 6. 2023-06-08. PMID:37289766. |
diabetic retinopathy (dr) is the primary retinal vascular complication of diabetes mellitus and a leading cause of visual impairment and blindness. |
2023-06-08 |
2023-08-14 |
Not clear |
| Eric Wang, Biao Feng, Subrata Chakrabart. MicroRNA 9 Is a Regulator of Endothelial to Mesenchymal Transition in Diabetic Retinopathy. Investigative ophthalmology & visual science. vol 64. issue 7. 2023-06-06. PMID:37279396. |
diabetic retinopathy (dr) is a significant cause of blindness. |
2023-06-06 |
2023-08-14 |
Not clear |
| Larisa Wewetzer, Linda A Held, Katja Goetz, Jost Steinhäuse. Determinants of the implementation of artificial intelligence-based screening for diabetic retinopathy-a cross-sectional study with general practitioners in Germany. Digital health. vol 9. 2023-06-05. PMID:37274367. |
diabetic retinopathy (dr) may lead to irreversible damage to the eye and cause blindness if diagnosed in its advanced stages. |
2023-06-05 |
2023-08-14 |
Not clear |
| Moein Ebrahimi, Paul Thompson, Andreas K Lauer, Sobha Sivaprasad, George Perr. The retina-brain axis and diabetic retinopathy. European journal of ophthalmology. 2023-06-01. PMID:37259525. |
diabetic retinopathy (dr) is a major contributor to permanent vision loss and blindness. |
2023-06-01 |
2023-08-14 |
Not clear |
| Ya-Chih Huang, Bo-Chun Chen, Kai-Fu Chang, Ming-Chang Hsieh, Gwo-Tarng Sheu, Chih-Yen Hsiao, Nu-Man Tsa. The alleviation effects of n-butylidenephthalide on apoptosis, senescence, and tight junction impairment of retinal pigment epithelium by activating Nrf-2/HO-1 signaling pathway in early diabetic retinopathy. Life sciences. 2023-06-01. PMID:37263489. |
diabetic retinopathy (dr) is a common complication of diabetes that causes visual impairment and blindness in adults. |
2023-06-01 |
2023-08-14 |
Not clear |
| S V Hemanth, Saravanan Alagarsam. Hybrid adaptive deep learning classifier for early detection of diabetic retinopathy using optimal feature extraction and classification. Journal of diabetes and metabolic disorders. vol 22. issue 1. 2023-05-31. PMID:37255780. |
diabetic retinopathy (dr) is one of the leading causes of blindness. |
2023-05-31 |
2023-08-14 |
Not clear |
| Zulvikar Syambani Ulhaq, Yuliono Trika Nur Hasan, Nanang Khulafa'ur Rosyidin, Lola Ayu Istifiani, Syafrizal Aji Pamungkas, Gita Vita Soray. A systematic proteomic profiling and pathway analysis of protein biomarkers in diabetic retinopathy with subsequent validation of the IL-6 upstream regulator. Journal of diabetes and metabolic disorders. vol 22. issue 1. 2023-05-31. PMID:37255833. |
diabetic retinopathy (dr) is a leading cause of irreversible blindness worldwide. |
2023-05-31 |
2023-08-14 |
Not clear |
| Shengyuan Huang, Guoqin Cao, Dong Dai, Qiuping Xu, Sunniva Ruiz, Satoru Shindo, Shin Nakamura, Toshihisa Kawai, Jiang Lin, Xiaozhe Ha. Frontiers in microbiology. vol 14. 2023-05-30. PMID:37250057. |
diabetic retinopathy (dr) is one of the leading causes of blindness. |
2023-05-30 |
2023-08-14 |
Not clear |
| Philipp Matten, Julius Scherer, Thomas Schlegl, Jonas Nienhaus, Heiko Stino, Michael Niederleithner, Ursula M Schmidt-Erfurth, Rainer A Leitgeb, Wolfgang Drexler, Andreas Pollreisz, Tilman Schmol. Multiple instance learning based classification of diabetic retinopathy in weakly-labeled widefield OCTA en face images. Scientific reports. vol 13. issue 1. 2023-05-29. PMID:37248309. |
diabetic retinopathy (dr), a pathologic change of the human retinal vasculature, is the leading cause of blindness in working-age adults with diabetes mellitus. |
2023-05-29 |
2023-08-14 |
human |
| Idan Bressler, Rachelle Aviv, Danny Margalit, Yovel Rom, Tsontcho Ianchulev, Zack Dvey-Aharo. Autonomous screening for laser photocoagulation in fundus images using deep learning. The British journal of ophthalmology. 2023-05-22. PMID:37217293. |
diabetic retinopathy (dr) is a leading cause of blindness in adults worldwide. |
2023-05-22 |
2023-08-14 |
Not clear |
| Dan Cao, Cong Wang, Liang Zho. Identification and comprehensive analysis of ferroptosis-related genes as potential biomarkers for the diagnosis and treatment of proliferative diabetic retinopathy by bioinformatics methods. Experimental eye research. 2023-05-19. PMID:37207868. |
proliferative dr (pdr) is the aggressive stage of dr with angiogenesis as a pathological hallmark, which is the main cause of blindness. |
2023-05-19 |
2023-08-14 |
Not clear |
| Jing Zhou, Bo Che. Retinal Cell Damage in Diabetic Retinopathy. Cells. vol 12. issue 9. 2023-05-14. PMID:37174742. |
the prevalence of diabetic retinopathy is approximately 30% of the diabetic population and untreated dr can eventually cause blindness. |
2023-05-14 |
2023-08-14 |
Not clear |
| Yeni Dwi Lestari, Gitalisa Andayani Adriono, Rizka Ratmilia, Christy Magdalena, Ratna Sitompu. Knowledge, attitude, and practice pattern towards diabetic retinopathy screening among general practitioners in primary health centres in Jakarta, the capital of Indonesia. BMC primary care. vol 24. issue 1. 2023-05-11. PMID:37170199. |
diabetic retinopathy (dr) is an emerging cause of visual impairment and blindness and is often detected in the irreversible stage. |
2023-05-11 |
2023-08-14 |
Not clear |
| Maria Georgiou, Ekatherine Prokopio. Diabetic retinopathy and the role of Omega-3 PUFAs: A narrative review. Experimental eye research. 2023-05-06. PMID:37149278. |
diabetic retinopathy (dr) is one of these and constitutes the most common cause of blindness amongst working-age individuals. |
2023-05-06 |
2023-08-14 |
Not clear |
| Lakshini Y Herat, Jennifer R Matthews, Elizabeth P Rakoczy, Markus P Schlaich, Vance B Matthew. Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy. Frontiers in bioscience (Landmark edition). vol 28. issue 4. 2023-04-28. PMID:37114550. |
diabetic retinopathy (dr) is a leading cause of end-stage blindness globally and is arguably one of the most disabling complications of both type 1 and type 2 diabetes. |
2023-04-28 |
2023-08-14 |
mouse |